Wälchli S - Search Results

1

Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S. Walseng E, et al. Among authors: walchli s. Sci Rep. 2017 Sep 6;7(1):10713. doi: 10.1038/s41598-017-11126-y. Sci Rep. 2017. PMID: 28878363 Free PMC article.

2

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J. Stronen E, et al. Among authors: walchli s. Scand J Immunol. 2009 Apr;69(4):319-28. doi: 10.1111/j.1365-3083.2008.02223.x. Scand J Immunol. 2009. PMID: 19284496 Free article.

3

Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif.

Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J. Abrahamsen IW, et al. Among authors: walchli s. Leukemia. 2010 Nov;24(11):1901-9. doi: 10.1038/leu.2010.186. Epub 2010 Sep 16. Leukemia. 2010. PMID: 20844564

4

Transiently redirected T cells for adoptive transfer.

Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM. Almåsbak H, et al. Among authors: walchli s. Cytotherapy. 2011 May;13(5):629-40. doi: 10.3109/14653249.2010.542461. Epub 2010 Dec 21. Cytotherapy. 2011. PMID: 21174490

5

A practical approach to T-cell receptor cloning and expression.

Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J. Wälchli S, et al. PLoS One. 2011;6(11):e27930. doi: 10.1371/journal.pone.0027930. Epub 2011 Nov 21. PLoS One. 2011. PMID: 22132171 Free PMC article.

6

Soluble T-cell receptors produced in human cells for targeted delivery.

Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J. Walseng E, et al. Among authors: walchli s. PLoS One. 2015 Apr 13;10(4):e0119559. doi: 10.1371/journal.pone.0119559. eCollection 2015. PLoS One. 2015. PMID: 25875651 Free PMC article.

7

Unpredicted phenotypes of two mutants of the TcR DMF5.

Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S. Tadesse FG, et al. Among authors: walchli s. J Immunol Methods. 2015 Oct;425:37-44. doi: 10.1016/j.jim.2015.06.006. Epub 2015 Jun 14. J Immunol Methods. 2015. PMID: 26079729

8

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA.

Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J. Mensali N, et al. Among authors: walchli s. Oncoimmunology. 2016 Feb 18;5(5):e1138199. doi: 10.1080/2162402X.2016.1138199. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467957 Free PMC article.

9

T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy.

Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M. Kyte JA, et al. Among authors: walchli s. Oncoimmunology. 2016 Oct 24;5(12):e1249090. doi: 10.1080/2162402X.2016.1249090. eCollection 2016. Oncoimmunology. 2016. PMID: 28123886 Free PMC article.

10

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.

Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G. Inderberg EM, et al. Among authors: walchli s. Oncoimmunology. 2017 Mar 17;6(4):e1302631. doi: 10.1080/2162402X.2017.1302631. eCollection 2017. Oncoimmunology. 2017. PMID: 28507809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters